CLB: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	25,262	10,738
Stock-based compensation	6,023	4,697
Depreciation and amortization	10,981	7,387
Assets write-down	34	34
Inventory write-off and obsolescence	2,429	1,620
Provision for credit losses	2,152	1,603
Changes in value of life insurance policies	1,851	834
Deferred income taxes	4,573	3,167
Insurance recovery on property, plant and equipment	6,830	1,557
Other non-cash items	-852	-566
Accounts receivable	615	3,717
Inventories	1,268	1,991
Prepaid expenses and other current assets	797	817
Other assets	351	109
Accounts payable	1,284	6,647
Accrued expenses	-3,370	-886
Unearned revenues	-2,074	-218
Other liabilities	1,797	587
Net cash provided by operating activities	29,085	20,583
Capital expenditures - operations	8,265	6,259
Capital expenditures - rebuilding of aberdeen facility	2,672	1,648
Proceeds from insurance recovery - aberdeen facility	9,951	4,678
Patents and other intangibles	2	0
Acquisitions, net of cash acquired	617	617
Proceeds from sale of assets	2,348	2,196
Net proceeds on life insurance policies	-778	-778
Net cash provided by (used in) investing activities	1,521	-872
Repayment of long-term debt	47,000	27,000
Proceeds from long-term debt	36,000	25,000
Debt issuance costs	1,706	-
Dividends paid	1,403	938
Repurchase of common stock	9,770	4,761
Equity related transaction costs	0	0
Other financing activity	-255	19
Net cash used in financing activities	-24,134	-7,680
Net change in cash and cash equivalents	6,472	12,031
Cash and cash equivalents at beginning of period	19,157	-
Cash and cash equivalents at end of period	25,629	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

CLB: the cashflow